Following the release of antibody-bound nanomicelle from the hydrogel, said nanomicelle targeted specific MUC16 antigens over-expressed on ovarian carcinoma cells within the ascitic fluid and within neoplastic nodules at distant sites within the peritoneal cavity. This evidence concerns the gene MUC16 and ovarian carcinoma.